Descubra el nuevo Chem-Impex: donde la innovación comienza con un vínculo.

Catalog Number:
21672
CAS Number:
138182-20-4
Sal de ciclohexilamonio del 6-cloro-3-indolil-β-D-glucurónido
Purity:
≥ 96 % (TLC)
Synonym(s):
Sal de ciclohexilamonio del ácido 6-cloro-3-indolil-β-D-glucurónico
Documents
$65.40 /250 mg
Tamaño
Request Bulk Quote
Información del producto

Sustratos cromogénicos para la ?-glucuronidasa

Número CAS
138182-20-4
Fórmula molecular
C14H14ClNO7 · C6H13N
Peso molecular
442.89
Número MDL
MFCD00153940
Rotación óptica
[a] D 20 = -70 ± 2 º (C=1 en DMF:H 2 O=1:1)
Condiciones
Conservar entre 0 y 8 °C.
Información general
Número CAS
138182-20-4
Fórmula molecular
C14H14ClNO7 · C6H13N
Peso molecular
442.89
Número MDL
MFCD00153940
Rotación óptica
[a] D 20 = -70 ± 2 º (C=1 en DMF:H 2 O=1:1)
Condiciones
Conservar entre 0 y 8 °C.
Propiedades
¡Pronto habrá más información sobre la propiedad!
-
Seguridad y normativas
Materiales peligrosos
-
Antibiótico
-
Regulado por la DEA
No
Advertencias
-
Aplicaciones

6-Chloro-3-indolyl-b-D-glucuronide cyclohexylammonium salt is widely utilized in research focused on:

  • Biochemical Assays: This compound is commonly used as a substrate in enzymatic assays to study the activity of β-glucuronidase, which is important in various metabolic pathways.
  • Drug Metabolism Studies: It helps researchers understand how drugs are processed in the body, particularly in studies related to glucuronidation, a key phase II metabolic reaction.
  • Cellular Research: The compound can be employed in cellular models to investigate the effects of glucuronidation on drug efficacy and toxicity, providing insights for pharmaceutical development.
  • Environmental Toxicology: It is used to assess the biotransformation of environmental pollutants, helping researchers evaluate the impact of these substances on ecosystems.
  • Pharmaceutical Development: The compound aids in the design of new drugs by providing a better understanding of metabolic pathways, which can lead to improved therapeutic profiles and reduced side effects.

Citas